Post-operative morbidity in Crohn's disease: what is the impact of patient-, disease- and surgery-related factors?
Crohn’s disease
Morbidity
Post-operative complications
Surgery
Journal
International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
accepted:
29
11
2021
pubmed:
12
1
2022
medline:
3
2
2022
entrez:
11
1
2022
Statut:
ppublish
Résumé
Over 50% of patients suffering from Crohn's disease (CD) require surgery in their lifetime. Predictors/risk factors of post-operative morbidity and mortality in CD are poorly investigated. We aimed to assess the risk factors of post-operative morbidity/mortality in CD. We performed a retrospective cohort study in which all CD patients operated and followed up at our tertiary Inflammatory Bowel Disease Centre from 2014 to 2019 were enrolled. For each patient, we evaluated patient-dependent, disease-dependent and surgery-dependent variables. All patients underwent small bowel and/or colic resections. Of the 165 operated patients, forty-two (25.5%) developed post-operative complications (major complication rate = 9.8%) including wound infection (12.1%), respiratory complications (4.8%), prolonged ileum (4.2%), anastomotic leak (3.6%), urinary infections (3%), abdominal abscess (2.4%), anastomotic bleeding (3.6%), abdominal bleeding (1.2%) and obstruction (0.6%). Two subjects (1.2%) required re-operation within 30 days, and one died. A surgery duration < 141 min was predictive of a better post-operative outcome (sensitivity 80.9%, specificity 43.1%, PPV 32.7%, NPV 86.9%). The multivariable analysis showed stricturing/fistulizing behaviour (OR 3.7, 95% CI 1.6-6.4, p = 0.02), need for total parenteral nutrition (OR 4.1, 95% CI 2.4-9.2, p = 0.01), pre-operative bowel cleansing (OR 0.6, 95% CI 0.41-0.83, p = 0.01) and surgery duration < 141 min (OR 0.2, 95% CI 0.08-0.7, p = 0.03) as the only risk factors associated with post-operative morbidities. About 25% of CD patients develop post-operative complications. Several patient-related, disease-related and surgery-related factors should be considered risk factors for post-operative morbidity. The recognition of these factors, as well as a multidisciplinary approach to the pre-operative management of CD, could reduce post-operative complications.
Identifiants
pubmed: 35013822
doi: 10.1007/s00384-021-04076-5
pii: 10.1007/s00384-021-04076-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
411-419Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Frolkis AD, Dykeman J, Negron ME, Debruyn J, Jette N, Fiest KM et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145:996–1006. https://doi.org/10.1053/j.gastro.2013.07.041
doi: 10.1053/j.gastro.2013.07.041
pubmed: 23896172
Rispo A, Imperatore N, Testa A, Bucci L, Luglio G, De Palma GD et al (2018) Combined endoscopic/sonographic-based risk matrix model for predicting one-year risk of surgery: a prospective observational study of a tertiary centre severe/refractory Crohn’s disease cohort. J Crohn’s Colitis 12:784–793. https://doi.org/10.1093/ecco-jcc/jjy032
doi: 10.1093/ecco-jcc/jjy032
Murthy SK, Begum J, Benchimol EI, Bernstein CN, Kaplan GG, McCurdy JD et al (2020) Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study. Gut 69:274–282. https://doi.org/10.1136/gutjnl-2019-318440
doi: 10.1136/gutjnl-2019-318440
pubmed: 31196874
Kopylov U, Ben-Horin S, Zmora O, Eliakim R, Katz LH (2012) Anti-tumor necrosis factor and postoperative complications in Crohn’s disease: systematic review and meta-analysis. Inflamm Bowel Dis 18:2404–2413. https://doi.org/10.1002/ibd.22954
doi: 10.1002/ibd.22954
pubmed: 22467533
Brouquet A, Maggiori L, Zerbib P, Lefevre JH, Denost Q, Germain A et al (2018) Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for ileocolonic Crohn disease: results of a prospective nationwide cohort. Ann Surg 267:221–228. https://doi.org/10.1097/SLA.0000000000002017
doi: 10.1097/SLA.0000000000002017
pubmed: 29300710
Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB et al (2013) Immunosuppressive therapy does not increase operative morbidity in patients with Crohn’s disease. J Clin Gastroenterol 47:491–495. https://doi.org/10.1097/MCG.0b013e3182677003
doi: 10.1097/MCG.0b013e3182677003
pubmed: 23090048
Shah RS, Bachour S, Jia X, Holubar SD, Hull TL, Achkar J-P et al (2021) Hypoalbuminaemia not biologic exposure is associated with postoperative complications in Crohn’s disease patients undergoing ileocolic resection. J Crohn’s Colitis 15:1142–1151. https://doi.org/10.1093/ecco-jcc/jjaa268
doi: 10.1093/ecco-jcc/jjaa268
Dong X, Tang S, Liu W, Qi W, Ye L, Yang X et al (2020) Prognostic significance of the Controlling Nutritional Status (CONUT) score in predicting postoperative complications in patients with Crohn’s disease. Sci Rep 10:19040. https://doi.org/10.1038/s41598-020-76115-0
doi: 10.1038/s41598-020-76115-0
pubmed: 33149221
pmcid: 7642365
Abdalla S, Benoist S, Maggiori L, Zerbib P, Lefevre JH, Denost Q et al (2021) Impact of preoperative enteral nutritional support on postoperative outcome in patients with Crohn’s disease complicated by malnutrition: results of a subgroup analysis of the nationwide cohort registry from the GETAID Chirurgie group. Color Dis Off J Assoc Coloproctology Gt Britain Irel 23:1451–1462. https://doi.org/10.1111/codi.15600
doi: 10.1111/codi.15600
Grass F, Ansell J, Petersen M, Mathis KL, Lightner AL (2019) Risk factors for 90-day readmission and return to the operating room following abdominal operations for Crohn’s disease. Surgery 166:1068–1075. https://doi.org/10.1016/j.surg.2019.08.006
doi: 10.1016/j.surg.2019.08.006
pubmed: 31548096
Bemelman WA, Warusavitarne J, Sampietro GM, Serclova Z, Zmora O, Luglio G et al (2018) ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohn’s Colitis 12:1–16. https://doi.org/10.1093/ecco-jcc/jjx061
doi: 10.1093/ecco-jcc/jjx061
Adamina M, Bonovas S, Raine T, Spinelli A, Warusavitarne J, Armuzzi A et al (2020) ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment. J Crohn’s Colitis 14:155–168. https://doi.org/10.1093/ecco-jcc/jjz187
doi: 10.1093/ecco-jcc/jjz187
Pellino G, Keller DS, Sampietro GM, Angriman I, Carvello M, Celentano V et al (2020) Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn’s disease. Tech Coloproctol 24:421–448. https://doi.org/10.1007/s10151-020-02183-z
doi: 10.1007/s10151-020-02183-z
pubmed: 32172396
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
doi: 10.1097/SLA.0b013e3181b13ca2
pubmed: 19638912
pmcid: 19638912
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 15273542
pmcid: 1360123
Kim NK, Senagore AJ, Luchtefeld MA, MacKeigan JM, Mazier WP, Belknap K et al (1997) Long-term outcome after ileocecal resection for Crohn’s disease. Am Surg 63:627–633
pubmed: 9202538
Nordgren SR, Fasth SB, Oresland TO, Hultén LA (1994) Long-term follow-up in Crohn’s disease Mortality morbidity and functional status. Scand J Gastroenterol 29:1122–1128. https://doi.org/10.3109/00365529409094898
doi: 10.3109/00365529409094898
pubmed: 7886401
Weston LA, Roberts PL, Schoetz DJ Jr, Coller JA, Murray JJ, Rusin LC (1996) Ileocolic resection for acute presentation of Crohn’s disease of the ileum. Dis Colon Rectum 39:841–846
doi: 10.1007/BF02053980
Graadal O, Nygaard K (1994) Crohn disease Long-term effects of surgical treatment. Tidsskr Nor Laegeforen 114:1603–1605
pubmed: 8079260
Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T et al (2004) Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99:878–883. https://doi.org/10.1111/j.1572-0241.2004.04148.x
doi: 10.1111/j.1572-0241.2004.04148.x
pubmed: 15128354
Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L (2008) Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 12:1730–1737. https://doi.org/10.1007/s11605-008-0630-8
doi: 10.1007/s11605-008-0630-8
pubmed: 18709514
Marchal L, D’Haens G, Van Assche G, Vermeire S, Noman M, Ferrante M et al (2004) The risk of post-operative complications associated with infliximab therapy for Crohn’s disease: a controlled cohort study. Aliment Pharmacol Ther 19:749–754. https://doi.org/10.1111/j.1365-2036.2004.01904.x
doi: 10.1111/j.1365-2036.2004.01904.x
pubmed: 15043515
Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR (2003) Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125:320–327
doi: 10.1016/S0016-5085(03)00883-7
Sampietro GM, Colombo F, Frontali A, Baldi CM, Carmagnola S, Cassinotti A et al (2018) Totally laparoscopic multi-stage restorative proctocolectomy for inflammatory bowel diseases A prospective study on safety efficacy and long-term results. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver 50:1283–1291. https://doi.org/10.1016/j.dld.2018.05.009
doi: 10.1016/j.dld.2018.05.009
Subramanian V, Saxena S, Kang J-Y, Pollok RCG (2008) Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 103:2373–2381. https://doi.org/10.1111/j.1572-0241.2008.01942.x
doi: 10.1111/j.1572-0241.2008.01942.x
pubmed: 18616660
Hartman C, Eliakim R, Shamir R (2009) Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol 15:2570–2578. https://doi.org/10.3748/wjg.15.2570
doi: 10.3748/wjg.15.2570
pubmed: 19496185
pmcid: 2691486
Lochs H, Dejong C, Hammarqvist F, Hebuterne X, Leon-Sanz M, Schütz T et al (2006) ESPEN Guidelines on Enteral Nutrition: Gastroenterology. Clin Nutr 25:260–274. https://doi.org/10.1016/j.clnu.2006.01.007
doi: 10.1016/j.clnu.2006.01.007
pubmed: 16698129
Ghoneima AS, Flashman K, Dawe V, Baldwin E, Celentano V (2019) High risk of septic complications following surgery for Crohn’s disease in patients with preoperative anaemia, ypoalbuminemia and high CRP. Int J Colorectal Dis 34:2185–2188. https://doi.org/10.1007/s00384-019-03427-7
doi: 10.1007/s00384-019-03427-7
pubmed: 31705193
Campbell MJ, Paull NB, Thirlby RC (2013) Transverse incisions for resection of ileocolic Crohn’s disease. Am Surg 79:279–283
doi: 10.1177/000313481307900327
Aarons CB (2013) Laparoscopic surgery for Crohn disease: a brief review of the literature. Clin Colon Rectal Surg 26:122–127. https://doi.org/10.1055/s-0033-1348051
doi: 10.1055/s-0033-1348051
pubmed: 24436660
pmcid: 3709945
Sevim Y, Akyol C, Aytac E, Baca B, Bulut O, Remzi FH (2017) Laparoscopic surgery for complex and recurrent Crohn’s disease. World J Gastrointest Endosc 9:149–152. https://doi.org/10.4253/wjge.v9.i4.149
doi: 10.4253/wjge.v9.i4.149
pubmed: 28465780
pmcid: 5394720
Spinelli A, Sacchi M, Bazzi P, Leone N, Danese S, Montorsi M (2012) Laparoscopic surgery for recurrent Crohn’s disease. Gastroenterol Res Pract 2012:381017. https://doi.org/10.1155/2012/381017
doi: 10.1155/2012/381017
pubmed: 22253619
pmcid: 3255167
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A et al (2017) Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: a randomised controlled open-abel, multicentre trial. Lancet Gastroenterol Hepatol 2:785–792. https://doi.org/10.1016/S2468-1253(17)30248-0
doi: 10.1016/S2468-1253(17)30248-0
pubmed: 28838644
Kono T, Ashida T, Ebisawa Y, Chisato N, Okamoto K, Katsuno H et al (2011) A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn’s disease. Dis Colon Rectum 54:586–592. https://doi.org/10.1007/DCR.0b013e318208b90f
doi: 10.1007/DCR.0b013e318208b90f
pubmed: 21471760
Luglio G, Rispo A, Imperatore N, Giglio MC, Amendola A, Tropeano FP et al (2020) Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn’s disease: the SuPREMe-CD study - a randomized clinical trial. Ann Surg 272:210–217. https://doi.org/10.1097/SLA.0000000000003821
doi: 10.1097/SLA.0000000000003821
pubmed: 32675483
Luglio G, Rispo A, Castiglione F, Imperatore N, Giglio MC, De Palma GD et al (2016) Kono-type anastomosis in a patient with severe multi-recurrent Crohn’s disease. Int J Colorectal Dis 31:1565–1566. https://doi.org/10.1007/s00384-016-2567-9
doi: 10.1007/s00384-016-2567-9
pubmed: 27026171
Peltrini R, Greco PA, Manfreda A, Luglio G, Bucci L (2020) Kono-S anastomosis after intestinal resection for Crohn’s disease. Updates Surg 72:335–340. https://doi.org/10.1007/s13304-019-00700-w
doi: 10.1007/s13304-019-00700-w
pubmed: 31897890
Shimada N, Ohge H, Kono T, Sugitani A, Yano R, Watadani Y et al (2019) Surgical recurrence at anastomotic site after bowel resection in Crohn’s disease: comparison of Kono-S and end-to-end anastomosis. J Gastrointest Surg 23:312–319. https://doi.org/10.1007/s11605-018-4012-6
doi: 10.1007/s11605-018-4012-6
pubmed: 30353491
Cioffi I, Marra M, Imperatore N, Pagano MC, Santarpia L, Alfonsi L et al (2020) Assessment of bioelectrical phase angle as a predictor of nutritional status in patients with Crohn’s disease: a cross sectional study. Clin Nutr 39:1564–1571. https://doi.org/10.1016/j.clnu.2019.06.023
doi: 10.1016/j.clnu.2019.06.023
pubmed: 31303525
Cioffi I, Imperatore N, Di Vincenzo O, Pagano MC, Santarpia L, Pellegrini L et al (2020) Evaluation of nutritional adequacy in adult patients with Crohn’s disease: a cross-sectional study. Eur J Nutr 59:3647–3658. https://doi.org/10.1007/s00394-020-02198-0
doi: 10.1007/s00394-020-02198-0
pubmed: 32072266
pmcid: 7669764